Use of inhibitors and antisense oligonucleotides of BTK for the treatment of proliferative mastocytosis

摘要

The present invention relates to a method for treating proliferative mastocytosis comprising administering a Bruton tyrosine kinase (BTK) inhibitor, a BTK antisense oligonucleotide or a vector expressing said antisense to a mammal in need of such treatment. The invention is more particularly suited for treating category II, III and IV mastocytosis.